CYP2D6 polymorphisms influence tamoxifen treatment outcomes in
Por um escritor misterioso
Descrição
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? - ScienceDirect
The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer
The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patients, BMC Cancer
Effects of CYP2D6 Genetic Polymorphism and Drug Interaction on the Metabolism of Dacomitinib
Full article: Genetic Influences in Breast Cancer Drug Resistance
Impact of CYP2D*6 in the adjuvant treatment of breast cancer patients with tamoxifen
CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis
Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype - ScienceDirect
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?, Expert Reviews in Molecular Medicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
